Vascular Leakage Program
Conditions with vascular leakage pathologies
Pre-clinicalActive
Key Facts
Indication
Conditions with vascular leakage pathologies
Phase
Pre-clinical
Status
Active
Company
About Akttyva Therapeutics
Akttyva Therapeutics is a private, early-stage biotech founded in 2021, headquartered in San Francisco with a listed office in Watertown, Massachusetts. The company is developing an evidence-based, AI-assisted drug discovery platform called AIDE v.2, which combines computational tools with experimental validation. Its initial pipeline targets diseases driven by vascular leakage, aiming to modulate endothelial vasculature function. As a pre-revenue, pre-clinical company, Akttyva's strategy hinges on validating its integrated platform to discover and advance novel therapeutics.
View full company profile